Comparison of diagnostic criteria for metabolic syndrome in a Rural Primary Care Center
DOI:
https://doi.org/10.35381/s.v.v6i1.2159Keywords:
Metabolic syndrome, abdominal circumference, obesity, dyslipidemia. (Source, DeCS).Abstract
Objective: To compare the diagnostic criteria for metabolic syndrome based on the NCEP/ATP-III, ALAD and IDF/NHLBI/AHA definitions based on its prevalence in a population aged 18-65 years in a rural primary care center during the period 2021. Methods: Descriptive observational, non-experimental, with a sample of 267 individuals. Results: It was found that there was a predominance of the male sex, which ranged between 27-69 years; in addition, 89.8% had a normal BMI. The prevalence was 59.2% under IDF/NHLBI/AHA, followed by ALAD with 41.9% and 33.7% NCEP/ATP-III. Likewise, moderate concordance was observed between NCEP/ATP-III and IDF /NHLBI/AHA and low concordance between NCEP/ATP-III and ALAD; ALAD and IDF /NHLBI/AHA. Conclusion: Metabolic syndrome should be assessed under more specific and adaptive criteria for the population at regional level, in order to provide relevant data for future studies.
Downloads
References
Reaven GM. Role of Insulin Resistance in Human Disease. Diabetes. 1988;37(12):1595-607.
Robles L, Carlos J. Metabolic syndrome: concept and practical application. An Fac Med. 2013;74(4):315-20.
Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep [Internet]. 2018;20(2).
Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Therapeutic Advances in Cardiovascular Disease. 2017;11(8):215-225. doi:10.1177/1753944717711379
Muñoz FL, Pou SA, Navarro-Lechuga E, et al. Criterio no bioquímico propuesto para la definición de síndrome metabólico en una población en desarrollo de América Latina [Proposed non-biochemical criteria for the definition of metabolic syndrome in a developing population in Latin America.]. Med Int Mex. 2021;37(3):313-323.
World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1, Diagnosis and classification of diabetes mellitus [Internet]. World Health Organization; 1999. Report No.: WHO/NCD/NCS/99.2. Disponible en: https://apps.who.int/iris/handle/10665/66040
Simmons RK, Alberti KGMM, Gale EAM, Colagiuri S, Tuomilehto J, Qiao Q, et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia. 1 de abril de 2010;53(4):600-5.
Expert Panel on Detection E and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 16 de mayo de 2001;285(19):2486-97.
Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, et al. Intra-Abdominal Fat Is a Major Determinant of the National Cholesterol Education Program Adult Treatment Panel III Criteria for the Metabolic Syndrome. Diabetes. 1 de agosto de 2004;53(8):2087-94.
Ford ES. Prevalence of the Metabolic Syndrome Defined by the International Diabetes Federation Among Adults in the U.S. Diabetes Care. 1 de noviembre de 2005;28(11):2745-9.
Consenso Latinoamericano de la Asociación Latinoamericana de Diabetes (ALAD). Epidemiología, diagnóstico, control, prevención y tratamiento del síndrome metabólico en adultos [Epidemiology, diagnosis, monitoring, prevention and treatment of metabolic syndrome in adults]. Rev Asoc Latinoam Diabetes. 18:25-44.
Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469-80.
Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [published correction appears in Circulation. 2005 Oct 25;112(17):e297] [published correction appears in Circulation. 2005 Oct 25;112(17):e298]. Circulation. 2005;112(17):2735-2752. doi:10.1161/CIRCULATIONAHA.105.169404
Medina-Lezama J, Pastorius CA, Zea-Diaz H, Bernabe-Ortiz A, Corrales-Medina F, Morey-Vargas OL, et al. Optimal Definitions for Abdominal Obesity and the Metabolic Syndrome in Andean Hispanics: The PREVENCION Study. Diabetes Care. 3 de marzo de 2010;33(6):1385-8.
Sempértegui F, Estrella B, Tucker KL, Hamer DH, Narvaez X, Sempértegui M, et al. Metabolic syndrome in elderly living in marginal peri-urban communities in Quito, Ecuador. Public Health Nutr. 2011;14(5):758-67.
Pérez-Galarza J, Baldeón L, Franco OH, Muka T, Drexhage HA, Voortman T, et al. Prevalence of overweight and metabolic syndrome, and associated sociodemographic factors among adult Ecuadorian populations: the ENSANUT-ECU study. J Endocrinol Invest. 2021;44(1):63-74.
Martínez MP, Vergara ID, Molano KQ, Pérez MM, Ospina AP. Síndrome metabólico en adultos: Revisión narrativa de la literatura. Arch Med. 2021;17(2):4.
Casapulla SL, Howe CA, Mora GR, Berryman D, Grijalva MJ, Rojas EW, et al. Cardiometabolic risk factors, metabolic syndrome and pre-diabetes in adolescents in the Sierra region of Ecuador. Diabetol Metab Syndr [Internet]. 2017;9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397823/
Fernández-Ruiz VE, Paniagua-Urbano JA, Solé-Agustí M, Ruiz-Sánchez A, Gómez-Marín J. Prevalencia de síndrome metabólico y riesgo cardiovascular en un área urbana de Murcia. Nutr Hosp. 2014;30(5):1077-83.
Vásquez CMA, Cordero LCA, Álvarez R, Valdiviezo A, Cordero G, Añez RJ, et al. Prevalencia y nivel de concordancia entre tres definiciones de síndrome metabólico en la ciudad de cuenca-Ecuador [Prevalence and level of agreement between three definitions of metabolic syndrome in the city of cuenca-Ecuador]. Av En Biomed. 2016;5(3):117-28.
Carvajal Carvajal C. Síndrome metabólico: definiciones, epidemiología, etiología, componentes y tratamiento [Metabolic syndrome: definitions, epidemiology, etiology, components and treatment]. Med Leg Costa Rica. 2017;34(1):175-93.
Organización Panamericana de la Salud. Prevención de la Obesidad [Obesity Prevention]. [Internet]. Disponible en: https://www.paho.org/es/temas/prevencion-obesidad
WMA - The World Medical Association. Declaración de la AMM sobre las Consideraciones Éticas de las Bases de Datos de Salud y los Biobancos [WMA Statement on Ethical Considerations of Health Databases and Biobanks]. [Internet]. Disponible en: https://acortar.link/gsA2GD
Diaz CIE, Zambrano A de los ÁM, Placencia LFP, Guerrero JET, Rey PJB, Martínez AMG, et al. Prevalencia de síndrome metabólico y factores asociados en adultos mayores de la parroquia de Baños, Cuenca [Prevalence of metabolic syndrome and associated factors in older adults in the parish of Baños, Cuenca]. Arch Venez Farmacol Ter. 2018;37(3):283-8.
Benavides DF, Zambrano ALP, Espinoza TMA. Prevalencia de síndrome metabólico: personal que labora en la Escuela de Medicina [Prevalence of metabolic syndrome: personnel working at the School of Medicine]. Universidad de Cuenca. Arch Venez Farmacol Ter. 2018;38(2):24-9.
Apolo Montero AM, Escobar Segovia KF, Herrera Vinelli IP, Arias Ulloa CA, Apolo Montero DA, Apolo Montero AM, et al. Análisis descriptivo del síndrome metabólico en trabajadores de empresas en la costa ecuatoriana, 2017 y 2018 [Descriptive analysis of metabolic syndrome in workers of companies on the Ecuadorian coast, 2017 and 2018]. Rev San Gregor. junio de 2020;(39):162-76.
Quiroz D, Quiroz D, Bognanno FJ, Marin M. Prevalencia de síndrome metabólico y factores de riesgo en la etnia Kariña, Estado Bolívar, Venezuela [Prevalence of metabolic syndrome and risk factors in the Kariña ethnic group, Bolivar State, Venezuela]. Rev Científica Cienc Médica. 2018;21(1):7-13.
Díaz-Ortega JL, Yupari-Azabache IL. Modelo de predicción para Síndrome metabólico en adultos de Trujillo [Prediction model for metabolic syndrome in adults of Trujillo], Perú. Rev Habanera Cienc Médicas. 2022;21(1):4369.
Chaves Pereira Reis VM, Santos Brant Rocha J, Fonseca AA, Ferreira Freitas R, Araújo Passos BM, Perim Baldo M, et al. A Comparison of the Prevalence of Metabolic Syndrome According to Different Definitions in Climacteric Women. Metab Syndr Relat Disord. 2021;19(8):436-42.
Hernández R, Herrera H, Carias D. Coincidencias y divergencias en las prevalencias del síndrome metabólico según IDF y ATP III en adultos de Caracas [Coincidences and divergences in the prevalence of metabolic syndrome according to IDF and ATP III in adults in Caracas]. An Venez Nutr [Internet]. 2014;27(2). Disponible en: http://www.analesdenutricion.org.ve/ediciones/2014/2/art-2/
Ramírez-López LX, Aguilera AM, Rubio CM, Aguilar-Mateus ÁM, Ramírez-López LX, Aguilera AM, et al. Síndrome metabólico: una revisión de criterios internacionales [Metabolic syndrome: a review of international criteria]. Rev Colomb Cardiol. febrero de 2021;28(1):60-6.
Tejada López YO, Choquehuanca Zambrano GM, Goicochea Ríos E del S, Vicuña Villacorta JE, Guzmán Aybar OY, Tejada López YO, et al. Perfil clínico-epidemiológico del síndrome metabólico en adultos atendidos en el hospital I Florencia de Mora EsSALUD [Clinical-epidemiological profile of the metabolic syndrome in adults attended at the hospital I Florencia de Mora EsSALUD]. Horiz Méd Lima [Internet]. 2020;20(4).
Torres-Valdez M, Ortiz-Benavides R, Sigüenza-Cruz W, Ortiz-Benavides A, Añez R, Salazar J, et al. Punto de corte de circunferencia abdominal para el agrupamiento de factores de riesgo metabólico: una propuesta para la población adulta de Cuenca, Ecuador [Abdominal circumference cut-off point for grouping metabolic risk factors: a proposal for the adult population of Cuenca, Ecuador]. Rev Argent Endocrinol Metab. 2016;53(2):59-66.
Wube TB, Nuru MM, Anbese AT. Comparative Prevalence Of Metabolic Syndrome Among Type 2 Diabetes Mellitus Patients In Hawassa University Comprehensive Specialized Hospital Using Four Different Diagnostic Criteria. Diabetes Metab Syndr Obes Targets Ther. 2019;12:1877-87.
Akobeng AK. Understanding type I and type II errors, statistical power and sample size. Acta Paediatr. 2016;105(6):605-9.
Niz-Ramos J, Niz-Ramos J. Las falacias de la p y significación estadística [The fallacies of p and statistical significance]. Ginecol Obstet México. 2020;88(8):536-41.
Pineda GA, Aparicio NER, Santander AE, Giménez L, Leguizamón H. Enfermedad arterial periférica determinada por índice tobillo-brazo en pacientes con síndrome metabólico [Peripheral arterial disease determined by ankle-brachial index in patients with metabolic syndrome]. Rev Virtual Soc Paraguaya Med Interna. 2018;49-58.
Paula HA de A, Ribeiro R de CL, Rosado LEFP de L, Pereira RSF, Franceschini S do CC. Comparison of the different definition criteria for the diagnosis of the metabolic syndrome in elderly women. Arq Bras Cardiol. 2010;95:346-53.
Roca-Sánchez-Moreno JD, Soto A, Núñez-Muñoz AL, Cruz-Vargas JADL, Quiñones-Laveriano DM. Comparación de diferentes definiciones de síndrome metabólico y su relación con la estimación del riesgo cardiovascular [Comparison of different definitions of metabolic syndrome and their relationship to cardiovascular risk estimation]. Rev Fac Med. 2022;70(2):e92602-e92602.
Cifuentes M, Salazar B, Cova Z, Granado A, Mociños C, Cedeño J, et al. Prevalencia de síndrome metabólico y grado de concordancia entre 2 clasificaciones diagnosticas en la población adulta de Ciudad Bolívar, Venezuela [Prevalence of metabolic syndrome and degree of concordance between 2 diagnostic classifications in the adult population of Ciudad Bolivar, Venezuela]. Sindrome Cardiometabolico. 2016;VI:8-19.
González-Chávez A, Elizondo-Argueta S, Zúñiga JS, Salgado GG, Guerrero-Romero F, Simental L. Prevalencia del síndrome metabólico entre adultos mexicanos no diabéticos, usando las definiciones de la OMS, NCEP-ATPIIIa e IDF [Prevalence of metabolic syndrome among non-diabetic Mexican adults, using WHO, NCEP-ATPIIIa and IDF definitions]. Rev Médica Hosp Gen México. 2008;71(1):11-9.
Agudelo-Flórez LA, Manco-Patiño DR, Giraldo-González EF, Campiño-Londoño JF, Pinto-Mejía J, Calvo-Betancur V, et al. Prevalencia del síndrome metabólico según criterios ALAD y ATP III en pacientes del programa de riesgo cardiovascular en San Carlos, Antioquia, Colombia [Prevalence of metabolic syndrome according to ALAD and ATP III criteria in patients of the cardiovascular risk program in San Carlos, Antioquia, Colombia]. Alad. 2019;9(3):2056.
Published
How to Cite
Issue
Section
License
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
